Bennett W - Search Results

1

Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor.

Kang DH, Kim YG, Andoh TF, Gordon KL, Suga S, Mazzali M, Jefferson JA, Hughes J, Bennett W, Schreiner GF, Johnson RJ. Kang DH, et al. Among authors: bennett w. Am J Physiol Renal Physiol. 2001 Apr;280(4):F727-36. doi: 10.1152/ajprenal.2001.280.4.F727. Am J Physiol Renal Physiol. 2001. PMID: 11249864 Free article.

2

Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity.

Shihab FS, Bennett WM, Yi H, Andoh TF. Shihab FS, et al. Am J Transplant. 2002 Feb;2(2):111-9. doi: 10.1034/j.1600-6143.2002.020201.x. Am J Transplant. 2002. PMID: 12099512 Free article.

3

Angiotensin II regulation of vascular endothelial growth factor and receptors Flt-1 and KDR/Flk-1 in cyclosporine nephrotoxicity.

Shihab FS, Bennett WM, Isaac J, Yi H, Andoh TF. Shihab FS, et al. Kidney Int. 2002 Aug;62(2):422-33. doi: 10.1046/j.1523-1755.2002.00452.x. Kidney Int. 2002. PMID: 12110003 Free article.

4

Nitric oxide modulates vascular endothelial growth factor and receptors in chronic cyclosporine nephrotoxicity.

Shihab FS, Bennett WM, Isaac J, Yi H, Andoh TF. Shihab FS, et al. Kidney Int. 2003 Feb;63(2):522-33. doi: 10.1046/j.1523-1755.2003.00757.x. Kidney Int. 2003. PMID: 12631117 Free article.

5

Cyclosporine nephrotoxicity.

Burdmann EA, Andoh TF, Yu L, Bennett WM. Burdmann EA, et al. Semin Nephrol. 2003 Sep;23(5):465-76. doi: 10.1016/s0270-9295(03)00090-1. Semin Nephrol. 2003. PMID: 13680536 Review.

6

Mycophenolate mofetil ameliorates arteriolopathy and decreases transforming growth factor-beta1 in chronic cyclosporine nephrotoxicity.

Shihab FS, Bennett WM, Yi H, Choi SO, Andoh TF. Shihab FS, et al. Am J Transplant. 2003 Dec;3(12):1550-9. doi: 10.1046/j.1600-6135.2003.00244.x. Am J Transplant. 2003. PMID: 14629285 Free article.

7

Cyclosporin induces renal proto-oncogene RNA message and increased transforming growth factor-beta prior to renal fibrosis: Modification by calcium channel blockade in the salt replete rat.

Saggi SJ, Andoh TF, Safirstein R, Bennett WM. Saggi SJ, et al. Nephrology (Carlton). 2004 Apr;9(2):58-64. doi: 10.1111/j.1440-1797.2003.00230.x. Nephrology (Carlton). 2004. PMID: 15056263

8

Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity.

Shihab FS, Bennett WM, Yi H, Choi SO, Andoh TF. Shihab FS, et al. Kidney Int. 2004 Apr;65(4):1262-71. doi: 10.1111/j.1523-1755.2004.00498.x. Kidney Int. 2004. PMID: 15086465 Free article.

9

Effect of cyclosporine and sirolimus on the expression of connective tissue growth factor in rat experimental chronic nephrotoxicity.

Shihab FS, Bennett WM, Yi H, Andoh TF. Shihab FS, et al. Am J Nephrol. 2006;26(4):400-7. doi: 10.1159/000095300. Epub 2006 Aug 22. Am J Nephrol. 2006. PMID: 16926534

10

Combination therapy with sirolimus and mycophenolate mofetil: effects on the kidney and on transforming growth factor-beta1.

Shihab FS, Bennett WM, Yi H, Choi SO, Andoh TF. Shihab FS, et al. Transplantation. 2004 Mar 15;77(5):683-6. doi: 10.1097/01.tp.0000116413.50765.f2. Transplantation. 2004. PMID: 15021829

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,539 results

Search Page

Filters